C82.28
Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of blood cancer that originates in the lymphatic system, specifically from B lymphocytes, which are a kind of white blood cell. When classified as Grade III, this lymphoma tends to grow more quickly than lower-grade forms and usually requires more aggressive treatment. The designation 'unspecified' indicates that this diagnosis has not further detailed the exact subtype of Grade III. When this condition affects lymph nodes across multiple sites, it demonstrates a more widespread disease process that can involve various parts of the lymphatic system throughout the body.
Causes & Symptoms
Clinical Causes: The exact cause of follicular lymphoma is unknown. Genetic mutations or alterations in the DNA of B cells are often involved in its development. Increased risk has been associated with age, particularly affecting adults over 60. Family history of lymphomas or other blood cancers can increase risk. Exposure to certain chemicals or environmental toxins may contribute to the likelihood of developing follicular lymphoma. Previous radiation exposure or other immune system disorders might also play a role.
Key Symptoms: Swollen lymph nodes, often painless, found in the neck, armpits, or groin. Persistent fatigue or feeling unusually tired. Unexplained weight loss. Fever and night sweats that do not resolve. Itching skin without an apparent cause. Frequent infections or other signs of immune system weakness.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical examination, imaging tests such as CT scans to locate lymph node swelling, and biopsies of affected tissue. Pathological analysis of lymph node tissue helps confirm the specific type and grade of lymphoma. Additional blood tests may be performed to evaluate overall health and organ function, and bone marrow biopsies can assess whether the marrow is involved. The staging process determines how widespread the disease is, which guides treatment options.
Treatment Protocols: Options depend on the stage and overall health of the patient, but commonly include chemotherapy, immunotherapy, targeted therapy, or a combination of these approaches. In some cases, radiation therapy may be used for localized disease. For advanced cases, combination regimens are employed to control disease progression. Recent treatment strategies also involve biological agents that target specific markers on cancer cells. Supportive care, including medications to manage symptoms and side effects, plays an important role throughout the treatment process.
Clinical Advice & FAQs
Billing Guidance
Is C82.28 a billable ICD-10 code?
Yes, C82.28 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.28?
Clinical documentation must specify the nature of Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
